Analysts are intrested in these 5 stocks: ( (DECK) ), ( (BEN) ), ( (ETN) ), ( (CPNG) ) and ( (QDEL) ). Here is a breakdown of their recent ratings and the rationale behind them.
Claim 55% Off TipRanks
Trade CPNG with leverageDeckers Outdoor is back on analysts’ radar as Bernstein’s Aneesha Sherman moves the stock up to a Hold, arguing that “the worst is over” after two years of slowing growth and heavy multiple compression. She now sees Deckers as fairly valued around a low-teens earnings multiple, with Hoka and Ugg growing modestly overall but gaining traction overseas.
Sherman’s $100 price target, just above the recent $98.54 share price, reflects a more balanced risk‑reward, not a fresh bull run, and she stresses that product innovation will decide the next big move. A strong 2027 pipeline in lifestyle and new styles could push earnings and the multiple higher toward a potential $130–135 scenario, while missteps could send the stock back toward the $70–75 range.
Franklin Resources is slowly rebuilding investor confidence as Morgan Stanley’s Michael Cyprys upgrades BEN to Equal‑weight, citing a “turnaround taking shape” after nine straight quarters of positive core net flows. The firm’s focus on separately managed accounts, ETFs and alternatives is starting to pay off, helping to offset ongoing fee pressure and a shift toward cheaper products.
Cyprys lifts his price target to $31, slightly above the recent $30.46 price, and values BEN at roughly 11 times expected 2027 earnings, a bit richer than its historical average but in line with current trading. He still sees a balanced setup, with a bull case of $46 and a bear case of $13, underscoring that market moves, fee compression and execution on flows and margins will remain key swing factors for investors.
Eaton’s story is more nuanced as Morgan Stanley’s Christopher Snyder steps back from a bullish stance and downgrades ETN to Hold despite robust demand and a powerful order book. First‑quarter earnings beat expectations, with double‑digit organic growth led by the Electrical Americas segment and surging orders that show little sign of slowing.
Yet Snyder points to pressured margins in 2026, driven by capacity additions and fresh cost inflation, as a major brake on earnings upgrades and share performance from here. With the stock already strong at around $422 and demand widely acknowledged, he argues the near‑term setup looks neutral, though he still sees a compelling opportunity further out as capacity turns from headwind to tailwind in 2027.
Coupang investors are being urged to temper expectations after UBS analyst Paul Hwang cuts the fast‑growing e‑commerce name to Neutral, warning of a slower‑than‑expected earnings recovery. First‑quarter adjusted EBITDA plunged and missed consensus, hurt by weaker product commerce growth, customer compensation costs and losses in newer businesses.
Hwang now projects 2026 adjusted EBITDA well below the Street, trims his forecasts through 2027 and lowers his 12‑month price target to $22.20, even as management maintains guidance for sizable losses in developing offerings. He does, however, flag potential upside catalysts from 2027 onward, including a return to earnings growth and a more active share‑repurchase program, making Coupang a name to watch rather than chase.
QuidelOrtho rounds out the list with a downgrade to Hold from Jefferies’ Tycho Peterson, who sees too many uncertainties around the company’s 2026 recovery narrative. Management’s outlook leans heavily on a broad second‑half rebound across China, the Middle East, respiratory testing and key platforms like LEX and OMX, assumptions Peterson views as “aspirational” given ongoing policy and geopolitical risks.
He also highlights mounting concerns over free‑cash‑flow recovery, rising leverage and limited visibility on earnings floors into 2027, even as the stock screens optically cheap at roughly five times 2026 EBITDA. With covenant constraints, succession questions and potential China policy hits looming, Peterson argues that valuation alone is unlikely to spark a rerating, leaving investors in wait‑and‑see mode despite the possibility of a strategic outcome down the line.